Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Agouron files first NDA submission

Dec. 24, 1996

Novel anti-HIV agent from NCI

Dec. 24, 1996

NanoSystems to develop novel formulation of HIV protease inhibitor

Dec. 23, 1996

IND filed for Cytel HIV therapeutic vaccine

Dec. 23, 1996

The role of host factors in HIV pathogenesis

Dec. 19, 1996

HemispheRx and Temple University enter new agreement for Oragen products

Dec. 19, 1996

MRC offers Fv1 gene for licensing

Dec. 17, 1996

New HIV-1 protease inhibitor in development at LG Chemical

Dec. 13, 1996

Procept's topical microbicide enters phase I in Europe

Dec. 12, 1996

Italian researchers described novel anti-HIV compounds

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...